Adaptive Biotechnologies CCO Susan Bobulsky sells 1,195 shares
Susan Bobulsky, Adaptive Biotechnologies’ Chief Commercial Officer, sold 1,195 common shares on Sep. 15 at $27 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.